pharma · Acute Schizophrenia · Schizophrenia · RVPH
REVIVA PHARMACEUTICALS HOLDINGS
REVIVA PHARMACEUTICALS HOLDINGS, INC.
REVIVA PHARMACEUTICALS HOLDINGS clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Cupertino, USA
- Employees
- 20
- Programs
- 3
- Drugs
- 1
- Patents
- 28
REVIVA PHARMACEUTICALS HOLDINGS projects
0 ClinicalTrials.gov programs sponsored by REVIVA PHARMACEUTICALS HOLDINGS.
REVIVA PHARMACEUTICALS HOLDINGS has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does REVIVA PHARMACEUTICALS HOLDINGS have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.